VECTIBIX PLUS OXALIPLATIN-BASED ADJUVANT TREATMENT OF RECTAL CANCER.

Trial Profile

VECTIBIX PLUS OXALIPLATIN-BASED ADJUVANT TREATMENT OF RECTAL CANCER.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 28 Mar 2012

At a glance

  • Drugs Panitumumab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
  • Indications Rectal cancer
  • Focus Adverse reactions
  • Acronyms VECTOX
  • Most Recent Events

    • 28 Mar 2012 Actual end date (20 Dec 2011) added as reported by European Clinical Trials Database.
    • 28 Mar 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
    • 14 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top